Immuncell-LC (GCC4002) / GC Biopharma, Green Cross Cell, Rivaara Immune  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

   Remove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Immuncell-LC (GCC4002) / GC Biopharma
NCT05053295: Investigator-initiated Pilot Study to Investigate the Efficacy and Safety of Immuncell-LC in Combination With Nivolumab (Opdivo) in Subjects With Advanced or Recurrent Gastric Cancer

Recruiting
N/A
20
RoW
autologous activated T lymphocyte, Immuncell-LC (Autologous activated T lymphocyte),
Gangnam Severance Hospital
Relapsed or Advanced Gastric Adenocarcinoma, Gastro-esophageal Junction Cancer
07/23
09/23

Download Options